Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Pinteon Therapeutics has raised $29.2M in total funding. The most recent round was Series B. The last funding was announced in January 2022.
Pinteon Therapeutics's investors include Morningside.
Pinteon Therapeutics is headquartered in Newton, United States.
Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Pinteon Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pinteon Therapeutics — Funding & Investors." VCBacked, January 11, 2022, https://www.vcbacked.co/company/pinteon-therapeutics. Accessed November 15, 2026.
VCBacked. (2022). Pinteon Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/pinteon-therapeutics
{{cite web |title=Pinteon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pinteon-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Pinteon Therapeutics? Request a listing update